跳至主要内容
临床试验/ACTRN12623000154606
ACTRN12623000154606尚未招募未知

The effects of topical Benzalkonium chloride (BAC) wound gel on microbial loads in chronic infections in Diabetes Related Foot Ulcers (DRFUs): An in vivo proof of concept study

South Western Sydney Local Health District0 个研究点目标入组 20 人开始时间: 2023年2月16日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Diagnosis of either 1 or type 2 diabetes mellitus
  • 2. Aged over 18 years
  • 3. Diabetes-related foot ulcer occurring below the malleolus stratified by; DRFU with a suspicion of chronic infection with foot ulcers greater than or equal to 5 week’s duration with no observed changes in wound metrics over a lead-in period of four consecutive weeks prior to enrolment.

排除标准

  • 1. Malignant ulcers
  • 2. Ulcers associated with chemotherapy
  • 3. Venous ulceration
  • 4. Thermal injuries (burns)
  • 5. Current uncontrolled anticoagulation therapy such as warfarin, clopidogrel and International Normalised Ratio (INR) >2.0
  • 6. New acute diabetes related foot infection requiring new antibiotic regimen
  • 7. Currently being treated for osteomyelitis.

研究者

相似试验